Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Rafael José Monteiro Da Silva Vieira

    Autor

  • Ana Isabel Alves De Sá E Sousa

    Autor

  • Rita Da Silva Amaral

    Autor

  • João De Almeida Lopes Da Fonseca

    Autor

  • Bernardo Manuel De Sousa Pinto

    Autor

Participantes de fora da FMUP

  • Pham-Thi, N
  • Anto, JM
  • Czarlewski, W
  • Bedbrook, A
  • Bosnic-Anticevich, S
  • Brussino, L
  • Canonica, GW
  • Cecchi, L
  • Cruz, AA
  • Fokkens, WJ
  • Gemicioglu, B
  • Haahtela, T
  • Ivancevich, JC
  • Klimek, L
  • Kuna, P
  • Kvedariene, V
  • Larenas-Linnemann, D
  • Morais-Almeida, M
  • Mullol, J
  • Niedoszytko, M
  • Okamoto, Y
  • Papadopoulos, NG
  • Patella, V
  • Pfaar, O
  • Regateiro, FS
  • Reitsma, S
  • Rouadi, PW
  • Samolinski, B
  • Sheikh, A
  • Taborda-Barata, L
  • Toppila-Salmi, S
  • Sastre, J
  • Tsiligianni, I
  • Valiulis, A
  • Ventura, MT
  • Waserman, S
  • Yorgancioglu, A
  • Zidarn, M
  • Zuberbier, T
  • Bousquet, J

Unidades de investigação

Abstract

BACKGROUND: Several studies have suggested an impact of allergic rhinitis on academic productivity. However, large studies with real-world data (RWD) are not available. OBJECTIVE: To use RWD to assess the impact of allergic rhinitis on academic performance (measured through a visual analog scale [VAS] education and the Work Productivity and Activity Impairment Questionnaire plus Classroom Impairment Questions: Allergy Specific [WPAIDCIQ:AS] questionnaire), and to identify factors associated with the impact of allergic rhinitis on academic performance. METHODS: We assessed data from the MASK-air mHealth app of users aged 13 to 29 years with allergic rhinitis. We assessed the correlation between variables measuring the impact of allergies on academic performance (VAS education, WPAI+CIQ:AS impact of allergy symptoms on academic performance, and WPAI+CIQ:AS percentage of education hours lost due to allergies) and other variables. In addition, we identified factors associated with the impact of allergic symptoms on academic productivity through multivariable mixed models. RESULTS: A total of 13,454 days (from 1970 patients) were studied. VAS education was strongly correlated with the WPAI+CIQ:AS impact of allergy symptoms on academic productivity (Spearman correlation coefficient = 0.71 [95% confidence interval (CI) = 0.58; 0.80]), VAS global allergy symptoms (0.70 [95% CI = 0.68; 0.71]), and VAS nose (0.66 [95% CI = 0.65; 0.68]). In multivariable regression models,immunotherapy showed a strong negative association with VAS education (regression coefficient =-2.32 [95% CI =-4.04;-0.59]). Poor rhinitis control, measured by the combined symptom-medication score, was associated with worse VAS education (regression coefficient = 0.88 [95% CI = 0.88; 0.92]), higher impact on academic productivity (regression coefficient = 0.69 [95% CI = 0.49; 0.90]), and higher percentage of missed education hours due to allergy (regression coefficient = 0.44 [95% CI = 0.25; 0.63]).<br />CONCLUSION: Allergy symptoms and worse rhinitis control are associated with worse academic productivity, whereas immunotherapy is associated with higher productivity. (C) 2022 American Academy of Allergy, Asthma & Immunology

Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Dados da publicação

ISSN/ISSNe:
2213-2198, 2213-2201

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE  Elsevier

Tipo:
Article
Páginas:
3008-3008
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 5

Citações Recebidas na Scopus: 19

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Allergic rhinitis; MASK; Real-world data; Mobile health; Academic productivity

Financiamento

Proyectos asociados

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021

Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527

Investigador Principal: João de Almeida Lopes da Fonseca

Ensaio Clínico Académico (mINSPIRERS) . 2021

Utilização em estudos observacionais do Registo de Asma Grave Portugal.

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Observacional Académico (RAG) . 2020

Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021

Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers

Investigador Principal: Bernardo Manuel De Sousa Pinto

Estudo Clínico Académico (SARS-CoV-2) . 2021

Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação